HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

thymogen

synthetic peptide; a nasal solution used in the treatment of AIDS-related Kaposi sarcoma
Also Known As:
IM 862 dipeptide; L-Glu-L-Trp; L-glutamyl-L-tryptophan; Thymogen
Networked: 37 relevant articles (6 outcomes, 4 trials/studies)

Relationship Network

Bio-Agent Context: Research Results

Experts

1. Iordanishvili, A K: 1 article (01/2020)
2. Kuznik, B I: 1 article (01/2020)
3. Pinelis, I S: 1 article (01/2020)
4. Pinelis, Y I: 1 article (01/2020)
5. Vasiliev, M A: 1 article (01/2020)
6. El'tsin, S S: 1 article (01/2011)
7. Petlenko, S V: 1 article (01/2011)
8. Smirnov, V S: 1 article (01/2011)
9. Bergeon, Julie A: 1 article (11/2007)
10. Toth, Istvan: 1 article (11/2007)

Related Diseases

1. Pyoderma
2. Neoplasms (Cancer)
3. Tuberculosis (Tuberculoses)
4. Infections
05/01/1995 - "[The efficacy of using thymogen in an experimental infection caused by Yersinia enterocolitica]."
05/01/1995 - "The evaluation of the characteristics of cell reactions in the lymphoid organs of the immune system (the thymus, the spleen, lymph nodes), nonspecific resistance and specific humoral response showed the effectiveness of using thymogen: this preparation produced an immunoregulatory effect in the infected animals; it decreased their polyclonal immune response, the development of autoimmune reactions and promoted the intensive development of delayed hypersensitivity (DH) after their enteral infection with Y.enterocolitica O9 and had no effect on the development of DH in the animals infected with Y.enterocolitica O3; it also enhanced the nonspecific resistance of the body, thus leading to a decrease in the dissemination of the infective agents in different organs and tissues and to their subsequent elimination from the body."
01/01/1996 - "In progredient infection an early administration of reaferon in combination with thymogen is thought valid which in many patients is sufficient to prevent the disease transformation into a chronic form."
05/01/1995 - "Thymogen was introduced into the animals on day 2 after their infection with Y.enterocolitica O3 and O9, introduced in daily injections of 10 micrograms/kg of body weight for 4 days. "
01/01/1990 - "A reduction of the total antibiotic resistance of the agent in foci of skin infection and normalization of the immunologic reactivity parameters were recorded in 23 patients with chronic pyodermas after a course of thymogen therapy. "
5. Virus Diseases (Viral Diseases)

Related Drugs and Biologics

1. Anti-Bacterial Agents (Antibiotics)
2. Immunologic Factors (Immunomodulators)
3. thymalin
4. Peptides (Polypeptides)
5. Radioisotopes (Radionuclides)
6. Dipeptides
7. Perforin
8. Pefloxacin
9. Streptomycin (Streptomycin Sulfate)
10. Rifampin (Rifampicin)

Related Therapies and Procedures

1. Therapeutics
2. Injections